Christopher P. Acevedo - 22 Jan 2026 Form 4 Insider Report for OS Therapies Inc (OSTX)

Role
Chief Financial Officer
Signature
/s/ Christopher P. Acevedo
Issuer symbol
OSTX
Transactions as of
22 Jan 2026
Net transactions value
$0
Form type
4
Filing time
13 Feb 2026, 16:42:16 UTC
Previous filing
19 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Acevedo Christopher P. Chief Financial Officer C/O OS THERAPIES INCORPORATED, 115 PULLMAN CROSSING ROAD, SUITE 103, GRASONVILLE /s/ Christopher P. Acevedo 13 Feb 2026 0002010225

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OSTX Common Stock 109,375 22 Jan 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSTX Stock options (right to buy) Award $0 +100,000 $0.000000 100,000 22 Jan 2026 Common Stock 100,000 $1.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 22, 2026, the reporting person was granted options to purchase 100,000 shares of the issuer's common stock pursuant to the terms and conditions of a stock option award agreement. These options vest in full on the one-year anniversary of the date of grant, provided that the reporting person is serving as an employee of the issuer on such date.